Will FDA Heed Its Outside Experts' Advice On COVID-19 Vaccines?
A panel of doctor and scientists raised questions about the expedited regulatory path the Food and Drug Administration is considering for COVID-19 vaccines.
A committee of advisers to the Food and Drug Administration generally supported the agency's approach to reviewing COVID-19 vaccines for emergency use during a public meeting Thursday.
But the raised concerns about the expedited regulatory path, including details of the clinical studies the agency will rely on to determine if the potential benefits
